90 related articles for article (PubMed ID: 30177492)
1. Design and synthesis of a luminescent iridium complex-peptide hybrid (IPH) that detects cancer cells and induces their apoptosis.
Masum AA; Yokoi K; Hisamatsu Y; Naito K; Shashni B; Aoki S
Bioorg Med Chem; 2018 Sep; 26(17):4804-4816. PubMed ID: 30177492
[TBL] [Abstract][Full Text] [Related]
2. Luminescent Iridium Complex-Peptide Hybrids (IPHs) for Therapeutics of Cancer: Design and Synthesis of IPHs for Detection of Cancer Cells and Induction of Their Necrosis-Type Cell Death.
Masum AA; Hisamatsu Y; Yokoi K; Aoki S
Bioinorg Chem Appl; 2018; 2018():7578965. PubMed ID: 30154833
[TBL] [Abstract][Full Text] [Related]
3. Design and Synthesis of Amphiphilic and Luminescent Tris-Cyclometalated Iridium(III) Complexes Containing Cationic Peptides as Inducers and Detectors of Cell Death via a Calcium-Dependent Pathway.
Hisamatsu Y; Shibuya A; Suzuki N; Suzuki T; Abe R; Aoki S
Bioconjug Chem; 2015 May; 26(5):857-79. PubMed ID: 25875312
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, and anticancer activity of iridium(III) complex-peptide hybrids that contain hydrophobic acyl groups at the N-terminus of the peptide units.
Naito K; Yokoi K; Balachandran C; Hisamatsu Y; Aoki S
J Inorg Biochem; 2019 Oct; 199():110785. PubMed ID: 31419676
[TBL] [Abstract][Full Text] [Related]
5. Synthetic constrained peptide selectively binds and antagonizes death receptor 5.
Vrielink J; Heins MS; Setroikromo R; Szegezdi E; Mullally MM; Samali A; Quax WJ
FEBS J; 2010 Apr; 277(7):1653-65. PubMed ID: 20156289
[TBL] [Abstract][Full Text] [Related]
6. Cyclometalated Iridium(III) Complex-Cationic Peptide Hybrids Trigger Paraptosis in Cancer Cells via an Intracellular Ca
Balachandran C; Yokoi K; Naito K; Haribabu J; Tamura Y; Umezawa M; Tsuchiya K; Yoshihara T; Tobita S; Aoki S
Molecules; 2021 Nov; 26(22):. PubMed ID: 34834120
[TBL] [Abstract][Full Text] [Related]
7. Ewing's sarcoma family tumors are sensitive to tumor necrosis factor-related apoptosis-inducing ligand and express death receptor 4 and death receptor 5.
Mitsiades N; Poulaki V; Mitsiades C; Tsokos M
Cancer Res; 2001 Mar; 61(6):2704-12. PubMed ID: 11289151
[TBL] [Abstract][Full Text] [Related]
8. Photochemical Properties of Red-Emitting Tris(cyclometalated) Iridium(III) Complexes Having Basic and Nitro Groups and Application to pH Sensing and Photoinduced Cell Death.
Kando A; Hisamatsu Y; Ohwada H; Itoh T; Moromizato S; Kohno M; Aoki S
Inorg Chem; 2015 Jun; 54(11):5342-57. PubMed ID: 25978770
[TBL] [Abstract][Full Text] [Related]
9. Design and synthesis of a luminescent cyclometalated iridium(III) complex having N,N-diethylamino group that stains acidic intracellular organelles and induces cell death by photoirradiation.
Moromizato S; Hisamatsu Y; Suzuki T; Matsuo Y; Abe R; Aoki S
Inorg Chem; 2012 Dec; 51(23):12697-706. PubMed ID: 23145911
[TBL] [Abstract][Full Text] [Related]
10. Cationic Amphiphilic Tris-Cyclometalated Iridium(III) Complexes Induce Cancer Cell Death via Interaction with Ca
Hisamatsu Y; Suzuki N; Masum AA; Shibuya A; Abe R; Sato A; Tanuma SI; Aoki S
Bioconjug Chem; 2017 Feb; 28(2):507-523. PubMed ID: 28032992
[TBL] [Abstract][Full Text] [Related]
11. Differential inhibition of TRAIL-mediated DR5-DISC formation by decoy receptors 1 and 2.
Mérino D; Lalaoui N; Morizot A; Schneider P; Solary E; Micheau O
Mol Cell Biol; 2006 Oct; 26(19):7046-55. PubMed ID: 16980609
[TBL] [Abstract][Full Text] [Related]
12. An iridium (III) complex as potent anticancer agent induces apoptosis and autophagy in B16 cells through inhibition of the AKT/mTOR pathway.
Tang B; Wan D; Wang YJ; Yi QY; Guo BH; Liu YJ
Eur J Med Chem; 2018 Feb; 145():302-314. PubMed ID: 29331753
[TBL] [Abstract][Full Text] [Related]
13. The tetravalent anti-DR5 antibody without cross-linking direct induces apoptosis of cancer cells.
Liu F; Si Y; Liu G; Li S; Zhang J; Ma Y
Biomed Pharmacother; 2015 Mar; 70():41-5. PubMed ID: 25776477
[TBL] [Abstract][Full Text] [Related]
14. Screening of a novel octamer peptide, CNSCWSKD, that induces caspase-dependent cell death.
Kaga C; Okochi M; Nakanishi M; Hayashi H; Kato R; Honda H
Biochem Biophys Res Commun; 2007 Nov; 362(4):1063-8. PubMed ID: 17822671
[TBL] [Abstract][Full Text] [Related]
15. [Correlation between sensitivity to TRAIL and expression level of DR5 on surface of tumor cells].
Ma YF; Zhang J; Zhao YP; Yang DL; Chen YH
Zhonghua Zhong Liu Za Zhi; 2004 Sep; 26(9):528-30. PubMed ID: 15555281
[TBL] [Abstract][Full Text] [Related]
16. Quinacrine induces apoptosis in cancer cells by forming a functional bridge between TRAIL-DR5 complex and modulating the mitochondrial intrinsic cascade.
Das S; Tripathi N; Preet R; Siddharth S; Nayak A; Bharatam PV; Kundu CN
Oncotarget; 2017 Jan; 8(1):248-267. PubMed ID: 27542249
[TBL] [Abstract][Full Text] [Related]
17. Luminescent dendritic cyclometalated iridium(III) polypyridine complexes: synthesis, emission behavior, and biological properties.
Zhang KY; Liu HW; Fong TT; Chen XG; Lo KK
Inorg Chem; 2010 Jun; 49(12):5432-43. PubMed ID: 20491455
[TBL] [Abstract][Full Text] [Related]
18. Mutations Enhancing Selectivity of Antitumor Cytokine TRAIL to DR5 Receptor Increase Its Cytotoxicity against Tumor Cells.
Gasparian ME; Bychkov ML; Yagolovich AV; Dolgikh DA; Kirpichnikov MP
Biochemistry (Mosc); 2015 Aug; 80(8):1080-91. PubMed ID: 26547077
[TBL] [Abstract][Full Text] [Related]
19. Regioselective aromatic substitution reactions of cyclometalated Ir(III) complexes: synthesis and photochemical properties of substituted Ir(III) complexes that exhibit blue, green, and red color luminescence emission.
Aoki S; Matsuo Y; Ogura S; Ohwada H; Hisamatsu Y; Moromizato S; Shiro M; Kitamura M
Inorg Chem; 2011 Feb; 50(3):806-18. PubMed ID: 21214169
[TBL] [Abstract][Full Text] [Related]
20. Novel and Versatile Imine-N-Heterocyclic Carbene Half-Sandwich Iridium(III) Complexes as Lysosome-Targeted Anticancer Agents.
Yang Y; Guo L; Tian Z; Gong Y; Zheng H; Zhang S; Xu Z; Ge X; Liu Z
Inorg Chem; 2018 Sep; 57(17):11087-11098. PubMed ID: 30133276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
